CONA
ABMD

Capital One National Association’s Abiomed Inc ABMD Stock Holding History

Capital One National Association’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.02M Sell
2,491
-4
-0.2% -$1.45K 0.07% 221
2018
Q1 		$726K Buy
2,495
+4
+0.2% +$1.01K 0.05% 275
2017
Q4 		$467K Sell
2,491
-9
-0.4% -$1.68K 0.03% 358
2017
Q3 		$422K Buy
2,500
+464
+23% +$70.2K 0.03% 374
2017
Q2 		$292K Sell
2,036
-12
-0.6% -$1.61K 0.02% 432
2017
Q1 		$256K Sell
2,048
-70
-3% -$8.11K 0.02% 458
2016
Q4 		$239K Sell
2,118
-581
-22% -$67.3K 0.02% 459
2016
Q3 		$347K Sell
2,699
-270
-9% -$32.3K 0.03% 399
2016
Q2 		$324K Sell
2,969
-126
-4% -$12.5K 0.03% 409
2016
Q1 		$293K Sell
3,095
-4,593
-60% -$388K 0.03% 438
2015
Q4 		$694K Sell
7,688
-655
-8% -$55.6K 0.06% 281
2015
Q3 		$774K Sell
8,343
-1,220
-13% -$107K 0.07% 256
2015
Q2 		$629K Sell
9,563
-204
-2% -$13.6K 0.06% 314
2015
Q1 		$699K Sell
9,767
-7,050
-42% -$383K 0.06% 296
2014
Q4 		$640K Sell
16,817
-4,958
-23% -$156K 0.06% 292
2014
Q3 		$541K Sell
21,775
-641
-3% -$16.2K 0.05% 299
2014
Q2 		$563K Sell
22,416
-4,271
-16% -$99.4K 0.05% 302
2014
Q1 		$695K Sell
26,687
-4,006
-13% -$111K 0.07% 287
2013
Q4 		$820K Sell
30,693
-14,905
-33% -$368K 0.08% 266
2013
Q3 		$869K Sell
45,598
-11,262
-20% -$257K 0.09% 256
2013
Q2 		$1.23M Buy
+56,860
New +$1.14M 0.13% 193

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital One National Association's ABMD Position: Q2 2018 in Review

Capital One National Association reduced its Abiomed Inc (ABMD) stake by 0.16% in Q2 2018, selling an estimated $1.45K and leaving 2,491 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #221.

Capital One National Association first reported a position in ABMD in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.23M in Q2 2013. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

  • Capital One National Association held 2,491 shares of Abiomed Inc worth $1.02M as of Q2 2018.
  • Capital One National Association sold 4 Abiomed Inc shares in Q2 2018, an estimated $1.45K.
  • Abiomed Inc made up 0.07% of Capital One National Association's portfolio in Q2 2018, its #221 holding.
  • Capital One National Association first reported a position in Abiomed Inc in Q2 2013 and has held it in 21 quarters since.
  • Capital One National Association's Abiomed Inc position peaked at $1.23M in Q2 2013.
  • 527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.